US Patent Issued to Sichuan Gooddoctor Panxi Pharmaceutical on Sept. 29 for "Polypeptide compound and use thereof in treatment of enteritis" (Chinese Inventor)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,267, issued on Sept. 29, was assigned to Sichuan Gooddoctor Panxi Pharmaceutical Co. Ltd. (Xichang City, China).

"Polypeptide compound and use thereof in treatment of enteritis" was invented by Funeng Geng (Sichuan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a new polypeptide. The new polypeptide shows a significant effect of relieving intestinal lumen distension in pharmacodynamic tests of a Brachydanio Rerio inflammatory bowel disease model and a rat inflammatory bowel disease model, and can be used for preparing a drug for treating enteritis, especially ulcerative colitis."

The patent was filed on Jan. 19, 2023, under Appl...